OCX.Oncocyte CORP

Form 4: Oncocyte Corp Director Patrick W. Smith Increases Stake Through Trust

Sentiment:

SEC Form 4

📋All filings for Oncocyte CORP
🔒Login to Follow

Director Patrick W. Smith, through a trust, acquired additional shares of Oncocyte Corp common stock in two transactions.

Summary

  • Patrick W. Smith, a director of Oncocyte Corp, has reported changes in beneficial ownership of the company's common stock.
  • On January 31, 2025, Smith acquired 890 shares at a price of $2.01 per share.
  • On February 4, 2025, Smith acquired an additional 25 shares at a price of $2.02 per share.
  • These shares are held indirectly through PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015, for which Smith serves as trustee.
  • Following these transactions, the total number of shares beneficially owned by Smith through the trust is 1,795,071.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of stock transactions by a company insider. The increase in holdings could be interpreted slightly positively, but without further context, it's difficult to gauge the overall impact.

Positives

  • A director increasing their stake in the company can be seen as a positive signal.

Industry Context

Form 4 filings are routine disclosures, but closely watched as they provide insights into the actions of company insiders.

Stakeholder Impact

  • The increased stake by a director could be viewed positively by shareholders.

Key Dates

DateDescription
05/01/2015Date of the SMITH IRREVOCABLE TRUST agreement.
01/31/2025Date of the first transaction: acquisition of 890 shares at $2.01.
02/04/2025Date of the second transaction: acquisition of 25 shares at $2.02; Date of Form 4 signature.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.